PREDICTIVE FACTORS OF BIOLOGIC DISEASEMODIFYING ANTI-RHEUMATIC DRUGS (BDMARD) USE IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS

被引:0
|
作者
Martins, A. [1 ,2 ]
Ganhao, S. [3 ]
Pinheiro, F. Oliveira [1 ,2 ]
Morais, C. [4 ]
Leuzinger-Dias, M. [5 ]
Rodrigues, M. [3 ]
Figueira, L. [5 ]
Brito, I. [2 ,3 ]
机构
[1] Sao Joao Univ Hosp Ctr, Rheumatol, Porto, Portugal
[2] Fac Med Univ Porto FMUP, Med, Porto, Portugal
[3] Sao Joao Univ Hosp Ctr, Pediat & Young Adult Rheumatol Unit, Porto, Portugal
[4] Sao Joao Univ Hosp Ctr, Pediat, Porto, Portugal
[5] Sao Joao Univ Hosp Ctr, Ophthalmol, Porto, Portugal
关键词
bDMARD;
D O I
10.1136/annrheumdis-2023-eular.1102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1414
引用
收藏
页码:1935 / 1936
页数:2
相关论文
共 50 条
  • [1] Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
    Ozer, Yavuz
    Yildiz, Mehmet
    Turan, Hande
    Tarcin, Gurkan
    Aydin, Dilek Bingol
    Gunalp, Aybuke
    Haslak, Fatih
    Konte, Elif Kilic
    Aslan, Esma
    Koker, Oya
    Bayramoglu, Elvan
    Sahin, Sezgin
    Adrovic, Amra
    Barut, Kenan
    Kasapcopur, Ozgur
    Evliyaoglu, Olcay
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 399 - 406
  • [2] Ovarian Reserve in Children with Juvenile Idiopathic Arthritis Using Biologic Disease-Modifying Anti-Rheumatic Drugs
    Ozer, Yavuz
    Yildiz, Mehmet
    Turan, Hande
    Tarcin, Gurkan
    Aydin, Dilek Bingol
    Gunalp, Aybuke
    Haslak, Fatih
    Konte, Elif Kilic
    Aslan, Esma
    Koker, Oya
    Bayramoglu, Elvan
    Sahin, Sezgin
    Adrovic, Amra
    Barut, Kenan
    Kasapcopur, Ozgur
    Evliyaoglu, Olcay
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 400 - 400
  • [3] Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
    Yavuz Ozer
    Mehmet Yildiz
    Hande Turan
    Gurkan Tarcin
    Dilek Bingol Aydin
    Aybuke Gunalp
    Fatih Haslak
    Elif Kilic Konte
    Esma Aslan
    Oya Koker
    Elvan Bayramoglu
    Sezgin Sahin
    Amra Adrovic
    Kenan Barut
    Ozgur Kasapcopur
    Olcay Evliyaoglu
    Clinical Rheumatology, 2024, 43 (1) : 399 - 406
  • [4] Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
    Kristen Hayward
    Carol A Wallace
    Arthritis Research & Therapy, 11
  • [5] Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
    Hayward, Kristen
    Wallace, Carol A.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (01)
  • [6] RETENTION RATE OF BIOLOGIC DISEASEMODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH DECREASED KIDNEY FUNCTION: RESULTS FROM THE IORRA COHORT
    Higuchi, T.
    Tanaka, E.
    Inoue, E.
    Abe, M.
    Saka, K.
    Sugano, E.
    Sugitani, N.
    Yoko, H.
    Ochiai, M.
    Yamaguchi, R.
    Ikari, K.
    Hisashi, Y.
    Harigai, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1324 - 1324
  • [7] PREDICTIVE FACTORS FOR SUCCESSFUL BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS DOSE TAPERING IN RHEUMATOID ARTHRITIS
    Loh, Min Yi
    Jones, Claire J.
    Peall, Adrian
    Trickey, Jeanette
    RHEUMATOLOGY, 2023, 62
  • [8] Disease modifying anti-rheumatic drugs in juvenile idiopathic arthritis: striving for individualized therapy
    Funk, Ryan S.
    Becker, Mara L.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (01): : 53 - 68
  • [9] Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database
    Hata, Takeo
    Hirata, Atsushi
    Ota, Ryosuke
    Hosohata, Keiko
    Nishihara, Masami
    Neo, Masashi
    Katsumata, Takahiro
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 843 - 853
  • [10] A Retrospective Study Comparing Refractoriness to Biologic Disease Modifying Anti-Rheumatic Drugs in Adults with Juvenile Idiopathic Arthritis as Compared to Those with Rheumatoid Arthritis
    Taba, Kiana
    Ortiz, Elizabeth
    ARTHRITIS & RHEUMATOLOGY, 2019, 71